[PHARMA] QoQ Quarter Result on 31-Mar-2013 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
15-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- 412.21%
YoY- -13.64%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 567,860 440,807 437,633 500,339 482,404 426,460 456,737 15.57%
PBT 33,007 13,461 9,605 36,924 4,248 28,493 27,618 12.58%
Tax -11,740 -9,291 -3,434 -11,771 -11,716 -2,957 -11,541 1.14%
NP 21,267 4,170 6,171 25,153 -7,468 25,536 16,077 20.44%
-
NP to SH 20,813 3,751 5,865 24,771 -7,934 25,247 15,713 20.54%
-
Tax Rate 35.57% 69.02% 35.75% 31.88% 275.80% 10.38% 41.79% -
Total Cost 546,593 436,637 431,462 475,186 489,872 400,924 440,660 15.39%
-
Net Worth 486,672 473,402 480,568 484,829 472,037 496,469 481,394 0.72%
Dividend
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Div 16,049 7,760 8,810 8,825 11,771 11,764 8,827 48.80%
Div Payout % 77.11% 206.90% 150.22% 35.63% 0.00% 46.60% 56.18% -
Equity
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Net Worth 486,672 473,402 480,568 484,829 472,037 496,469 481,394 0.72%
NOSH 258,868 258,689 258,370 117,676 117,715 117,646 117,700 68.87%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 3.75% 0.95% 1.41% 5.03% -1.55% 5.99% 3.52% -
ROE 4.28% 0.79% 1.22% 5.11% -1.68% 5.09% 3.26% -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 219.36 170.40 169.38 425.18 409.81 362.49 388.05 -31.56%
EPS 8.04 1.45 2.27 21.05 -6.74 21.46 13.35 -28.61%
DPS 6.20 3.00 3.41 7.50 10.00 10.00 7.50 -11.88%
NAPS 1.88 1.83 1.86 4.12 4.01 4.22 4.09 -40.35%
Adjusted Per Share Value based on latest NOSH - 117,676
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 39.40 30.59 30.37 34.72 33.47 29.59 31.69 15.57%
EPS 1.44 0.26 0.41 1.72 -0.55 1.75 1.09 20.33%
DPS 1.11 0.54 0.61 0.61 0.82 0.82 0.61 48.88%
NAPS 0.3377 0.3285 0.3334 0.3364 0.3275 0.3445 0.334 0.73%
Price Multiplier on Financial Quarter End Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 -
Price 4.45 4.82 4.49 8.26 8.10 7.55 10.18 -
P/RPS 2.03 2.83 2.65 1.94 1.98 2.08 2.62 -15.60%
P/EPS 55.35 332.41 197.80 39.24 -120.18 35.18 76.25 -19.18%
EY 1.81 0.30 0.51 2.55 -0.83 2.84 1.31 23.97%
DY 1.39 0.62 0.76 0.91 1.23 1.32 0.74 52.06%
P/NAPS 2.37 2.63 2.41 2.00 2.02 1.79 2.49 -3.23%
Price Multiplier on Announcement Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 -
Price 4.29 4.72 4.66 9.26 7.80 8.25 8.83 -
P/RPS 1.96 2.77 2.75 2.18 1.90 2.28 2.28 -9.56%
P/EPS 53.36 325.52 205.29 43.99 -115.73 38.44 66.14 -13.30%
EY 1.87 0.31 0.49 2.27 -0.86 2.60 1.51 15.27%
DY 1.45 0.64 0.73 0.81 1.28 1.21 0.85 42.62%
P/NAPS 2.28 2.58 2.51 2.25 1.95 1.95 2.16 3.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment